Represents one of the largest cell culture biomanufacturing sites in North America, which will employ 1,400 people by 2031
Ultra-high purity surfactant for biologics and parenteral drug formulations
Relonchem receives marketing authorization for Moxonidine tablets
Hengrui is eligible to receive regulatory and commercial milestone payments of up to US$1.093 billion
Collaboration combines Lunit's AI expertise with Agilent's diagnostic leadership to revolutionize biomarker testing and enhance precision medicine capabilities
Sessions will cover process mapping, cost optimisation, data-driven decision-making, cybersecurity, and sustainable manufacturing practices
The entity will undertake the installation, operation, and maintenance of sewage treatment plants
Subscribe To Our Newsletter & Stay Updated
